ÇAMLI PULAT, Ç. Et Al. 2023. RESVERATROL AND CDK4/6 INHIBITOR RIBOCICLIB: UNLEASHING SYNERGISTIC POTENTIAL IN BREAST CANCER CELLS. 11. INTERNATIONAL SUMMIT SCIENTIFIC RESEARCH CONGRESS , (Turkey).

ÇAMLI PULAT, Ç., İLHAN, M. S., & ATMACA İLHAN, H., (2023). RESVERATROL AND CDK4/6 INHIBITOR RIBOCICLIB: UNLEASHING SYNERGISTIC POTENTIAL IN BREAST CANCER CELLS . 11. INTERNATIONAL SUMMIT SCIENTIFIC RESEARCH CONGRESS, Turkey

ÇAMLI PULAT, ÇİSİL, MUHAMMED SÜLEYMAN İLHAN, And HARİKA ATMACA İLHAN. "RESVERATROL AND CDK4/6 INHIBITOR RIBOCICLIB: UNLEASHING SYNERGISTIC POTENTIAL IN BREAST CANCER CELLS," 11. INTERNATIONAL SUMMIT SCIENTIFIC RESEARCH CONGRESS, Turkey, 2023

ÇAMLI PULAT, ÇİSİL Ç. Et Al. "RESVERATROL AND CDK4/6 INHIBITOR RIBOCICLIB: UNLEASHING SYNERGISTIC POTENTIAL IN BREAST CANCER CELLS." 11. INTERNATIONAL SUMMIT SCIENTIFIC RESEARCH CONGRESS , Turkey, 2023

ÇAMLI PULAT, Ç. İLHAN, M. S. And ATMACA İLHAN, H. (2023) . "RESVERATROL AND CDK4/6 INHIBITOR RIBOCICLIB: UNLEASHING SYNERGISTIC POTENTIAL IN BREAST CANCER CELLS." 11. INTERNATIONAL SUMMIT SCIENTIFIC RESEARCH CONGRESS , Turkey.

@conferencepaper{conferencepaper, author={ÇİSİL ÇAMLI PULAT Et Al. }, title={RESVERATROL AND CDK4/6 INHIBITOR RIBOCICLIB: UNLEASHING SYNERGISTIC POTENTIAL IN BREAST CANCER CELLS}, congress name={11. INTERNATIONAL SUMMIT SCIENTIFIC RESEARCH CONGRESS}, city={}, country={Turkey}, year={2023}}